Mirdametinib (GMP)

Overview

Mirdametinib (PD0325901) (GMP) is Mirdametinib ( HY-10254 ) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Mirdametinib is an orally active, selective and non-ATP-competitive MEK inhibitor.

Application

Products | Products > GMP Small Molecules | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > MEK

Product Information

• Catalog No.: HY-10254G
• CAS No.: 391210-10-9
• Molecular Formula: C16H14F3IN2O4
• Molecular Weight: 482.19
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source